Table 2.
CDVA (log MAR) and CRT (μm) as mean ± standard deviation (range) at baseline and after 12 months with regard to naïve status and indication for surgery.
| Parameter | All eyes | ERM | RRD | |||
|---|---|---|---|---|---|---|
| Naïve (n = 18) | Pretreated (n = 43) | Naïve (n = 15) | Pretreated (n = 31) | Naïve (n = 3) | Pretreated (n = 12) | |
| CDVA at baseline | 0.82 ± 0.32 (0.2–1.3) | 0.55 ± 0.27 (0.1–1.1) | 0.87 ± 0.30 (0.4–1.3) | 0.55 ± 0.28 (0.1–1.2) | 0.57 ± 0.4 (0.2–1.0) | 0.54 ± 0.25 (0.2–1.0) |
| CDVA at 12M | 0.59 ± 0.33 (0.1–1.2) | 0.43 ± 0.28 (0–1.2) | 0.57 ± 0.33 (0.1–1.1) | 0.41 ± 0.25 (0.1–1.0) | 0.70 ± 0.36 (0.3–1.0) | 0.49 ± 0.35 (0–1.2) |
| p value | 0.008 ∗ | 0.003 ∗ | <0.0001 † | 0.004 ∗ | 0.655∗ | 0.410† |
| CRT at baseline | 472.4 ± 129.4 (285–677) | 507.2 ± 114.9 (346–645) | 485.9 ± 133.3 (285–677) | 525.1 ± 121.0 (350–645) | 405.0 ± 98.8 (302–499) | 460.9 ± 85.2 (346–639) |
| CRT at 12M | 380.2 ± 109.9 (225–660) | 365.5 ± 102.5 (243–733) | 377.6 ± 104.3 (225–660) | 365.7 ± 111.7 (243–733) | 393.3 ± 161.9 (245–566) | 365.1 ± 78.1 (250–510) |
| p value | 0.031 ∗ | <0.0001 ∗ | 0.017 † | <0.0001 ∗ | 1.0∗ | 0.08 † |
CDVA: corrected distance visual acuity; CRT: central retinal thickness; ERM: epiretinal membrane; RRD: rhegmatogenous retinal detachment. ∗Wilcoxon test; †paired t-test.